Evidence map›Paper›PMID 34063160›Full record

ArticleViruses2021

Clinical Characteristics and Outcomes of COVID-19 in West Virginia.

Sijin Wen, Apoorv Prasad, Kerri Freeland, Sanjiti Podury, Jenil Patel, Roshan Subedi, Erum Khan, Medha Tandon, Saurabh Kataria, Wesley Kimble and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Viruses, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Sijin WenDepartment of Biostatistics, West Virginia University, Morgantown, WV 26505, USA.ORCID 0000-0002-6955-2917
Apoorv PrasadBerkeley Medical Center, Department of Neurology, West Virginia University, Morgantown, WV 25401, USA.
Kerri FreelandDepartment of Biostatistics, West Virginia University, Morgantown, WV 26505, USA.
Sanjiti PoduryDepartment of Medicine, Army College of Medical Sciences, New Delhi 110010, Delhi, India.
Jenil PatelDepartment of Epidemiology, Human Genetics and Environmental Sciences, The University of Texas Health Science Center at Houston (UTHealth) School of Public Health, Dallas, TX 75235, USA.
Roshan SubediResearch Section, Nepal Health Research Council, Kathmandu 44600, Nepal.ORCID 0000-0002-8279-4777
Erum KhanDepartment of Medicine, B.J. Medical College and Civil Hospital, Ahmedabad 380016, Gujarat, India.
Medha TandonDepartment of Neurology, University of Pittsburgh Medical Center, Pittsburgh, PA 15215, USA.ORCID 0000-0003-1818-2669
Saurabh KatariaDepartment of Neurology, Louisiana State University, Health Sciences Center, Shreveport, LA 71130, USA.ORCID 0000-0001-8104-3085
Wesley KimbleWest Virginia Clinical and Translational Science Institute, Morgantown, WV 26505, USA.
Shitiz SriwastavaWest Virginia Clinical and Translational Science Institute, Morgantown, WV 26505, USA.ORCID 0000-0001-6844-3287

Funding

West Virginia IDEA-CTRU54GM104942 · NIGMS · WEST VIRGINIA UNIVERSITY · PI Laura F. Gibson · 2012 to 2026
$81.0M
NIGMS NIH HHS U54 GM104942
6 · The paper itself

Abstract

This study examines the clinical characteristics, outcomes and types of management in SARS-CoV-2 infected patients, in the hospitals affiliated with West Virginia University. We included patients from West Virginia with SARS-CoV-2 infection between 15 April to 30 December 2020. Descriptive analysis was performed to summarize the characteristics of patients. Regression analyses were performed to assess the association between baseline characteristics and outcomes. Of 1742 patients, the mean age was 47.5 years (±22.7) and 54% of patients were female. Only 459 patients (26.3%) reported at least one baseline symptom, of which shortness of breath was most common. More than half had at least one comorbidity, with hypertension being the most common. There were 131 severe cases (7.5%), and 84 patients (4.8%) died despite treatment. The mean overall length of hospital stay was 2.6 days (±6.9). Age, male sex, and comorbidities were independent predictors of outcomes. In this study of patients with SARS-CoV-2 infection from West Virginia, older patients with underlying co-morbidities had poor outcomes, and the in-hospital mortality was similar to the national average.

Indexed as

AdultAgedComorbidityCOVID-19FemaleHospitalizationHumansMaleMiddle AgedSARS-CoV-2Treatment OutcomeWest VirginiaCOVID-19mortalitySARS-CoV-2severity

Identifiers

PMID34063160
PMCPMC8148202

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.